维普中文期刊产品整合服务
40篇 您的检索式:作者名="Joshi MD"
    题名 作者 年代 出处 被引量
1Adrenocorticosteroid therapy in alcoholic hepatitis显示文摘Bennett L. Blitzer MD Milton G. Mutchnick MD Prakash H. Joshi MD Michael M. Phillips MD J. Michael Fessel MD Harold O. Conn MD 1977The American Journal of Digestive Diseases1977,,6:2
2Reproducible,ultra highthroughput formation of multicellular organization from single cell suspension-derived human embryonic stem cell aggregates显示文摘Ungrin MD Joshi C Nica A 2008PLoS One2008,3,2:1
3Age-related hearing loss and its association with reactive oxygen species and mitochondrial DNA damage显示文摘Seidman MD Ahmad N Joshi D 2004Acta Otolaryngol2004,,552:1
4MUC1-C oncoprotein func- tions as a direct activator of the nuclear factor-kappa B p65 transcrip- tion factor显示文摘Ahmad R Raina D Joshi MD 2009Cancer Res2009,69,17:1
5MUC1 oncoprotein is a druggable target in human prostate caneer cells显示文摘Joshi MD Ahmad R Yin L 2009Mol Caneer Ther2009,8,11:1
6MUCI-C Oncoprotein Functions as a direct activator of the nuclear factor-kappa B p65 transcription factor显示文摘Ahmad R Raina D Joshi MD et aI 2009Cancer Res2009,69,17:1
7Age-related hearing loss and its association with reactive oxygen species and mitochondrial DNA damage显示文摘Seidman MD Ahmad N Joshi D 2004Acta Otolaryngol2004,124,552:1
8右旋美托咪啶-咪达唑仑与丙泊酚用于小儿磁共振检查中麻醉维持的比较显示文摘背景右旋美托咪啶是一种仪,受体激动剂,目前正在研究其是否适合用于小儿麻醉。本研究旨在比较右旋美托咪啶一咪达唑仑与丙泊酚对于七氟烷麻醉儿童磁共振扫描(M对)中的药效学反应差异。方法40例1~10岁,ASA1或2级,拟行MRI检查的患儿,随机分为2组,两组均用七氟烷诱导,一组以右旋美托咪啶.咪达唑仑维持麻醉,另一组以丙泊酚维持麻醉。右旋美托咪啶组先静注负荷量(1μg/kg)后持续泵入(0.5μg·kg^-1·h^-1)。开始泵注后静注咪达唑仑(0.1mg/kg)。丙泊酚持续泵入(250—300μg·kg^-1·min^-1)。由一名不了解麻醉方案的护士来记录复苏时间及血流动力学变化。结果右旋美托咪啶组手术后完全恢复及出院时间明显长于(约15分钟)丙泊酚组。与丙泊酚组比较,右旋美托咪啶组心率减慢,收缩压增高。两组呼吸系统指标相近。恢复过程中,两组血流动力学反应相近。在麻醉及手术后恢复过程中,心肺指标均在同年龄段儿童的正常范围内。无麻醉意外发生。结论在MRI检查中,右旋美托咪啶.咪达唑仑提供足够的麻醉深度,但-I丙泊酚相比麻醉复苏时间稍长。与丙泊酚组比较,使用右旋美托咪啶的患儿心率慢、收缩压高。两种方式的呼吸系统指标相近。Christopher Heard, MBChB, FRCA Frederick Burrows, MD Kristin Johnson, PharmD Prashant Joshi, MD James Houck, MD Jerrold Lerman FRCPC, FANZCA 马敏(译) 江海星(译) 饶艳(校) 王焱林(校) 2010麻醉与镇痛2010,,2:1
9Total lymphocyte count as a surrogate marker for CD4^+ cell count in initiating antiretroviral therapy at Kenyatta National Hospital, Nairobi显示文摘Gitura B Joshi MD Lule GN 2007East Afr Med J2007,84,10:1
10Platelet functions in patients with meningococcal meningitis at the Kenyatta National Hospital,Nairobi显示文摘Amayo EO Kayima JK Joshi MD 2002East Afr Med J2002,79,8:1
11Lipid nanoparticles for parenteral delivery of actives 显示文摘Joshi MD Mtiller RH 2009Eur J Pharm Biopharm2009,71,2:1
12Parasitic diseases: Liposomes and polymeric nanoparticles versus lipid nanoparticles 显示文摘Date AA Joshi MD Patravale VB 2007Adv Drug Deliv Rev2007,59,6:1
13Scleral changes in chicks with form deprivation myopia 显示文摘 Joshi HB Nickla DL 1990Curr Eye Res1990,9,12:1
14Solid lipid nanoparticles (SLN) of tretinoin: potential in topical delivery 显示文摘Shah KA Date AA Joshi MD 2007Int J Pharm2007,345,12:1
15Age-related hearing loss and its association with reactive oxygen species and mito- chondrial DNA damage显示文摘Seidman MD Ahmad N Joshi D 2004Acta Otolaryngol2004,552,:1
16Direct targeting of the mucin1 oncoprotein blocks survival and tumorigenicity of human breastcarcinoma cells显示文摘Raina D Ahmad R Joshi MD 2009Cancer Res2009,69,12:1
17Aortic cobwebs:all an- atomic marker identifying the false lumen in aortic dissection- imaging and pathologic correlation显示文摘Williams DW Joshi A Dake MD 1994Radiology1994,190,:1
18MUC1-C oncoprotein functions as a direct activator of the nuclear factor-kappaB p65 transcription factor显示文摘Ahmad R Raina D Joshi MD 0,,17:1
19Cotton mealybug, Phenacoccus solenopsis Tinsley显示文摘Joshi MD Butani PG Patel VN 2010Agricultural Reviews2010,31,2:1
20Parasitic diseases: Iiposomes and polymeric nanoparticles versus lipid nanoparticles 显示文摘Date AA Joshi MD Patravale VB 2007Advance Drug Delivery Reviews2007,9,:1
返回顶部 每页显示:
共2页 首页 上一页 第1页 下一页 末页 /2 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费